86 results
DEFA14A
CC
Chemours Company
9 May 24
Additional proxy soliciting materials
4:15pm
commitment to the diversity of our Board. We are committed to having one or more highly qualified new directors who are ethnically or racially diverse
8-K
EX-10.1
k0hub0
23 Aug 23
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-99.1
af6xd yxzxm
1 Aug 23
Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million
8:04am
8-K
EX-99.1
jukry6zoba0cizd
6 Jun 23
Company Appoints Jonathan Lock as new CFO and Promotes Matt Abbott to Executive Team as SVP, Chief Enterprise Transformation Officer
6:46am
8-K
EX-99.2
96oklw ay388nm
29 Mar 23
Third Amendment to Amended and Restated Receivables Purchase Agreement
4:07pm
8-K
EX-99.2
nwnc7xr8se xa
25 Oct 22
The Chemours Company Reports Third Quarter 2022 Results
4:21pm
8-K
EX-99.1
vhobuk
22 Aug 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.2
145rg 1hb
28 Jul 22
The Chemours Company Reports Robust Second Quarter 2022 Results
4:23pm
8-K
EX-99.1
b1eyuju
10 Feb 22
The Chemours Company Reports Solid Fourth Quarter and Full Year 2021 Results, Provides Strong Full Year 2022 Outlook
4:45pm